ALXN - Alexion Pharmaceuticals Inc (ALXN) CEO Ludwig Hantson on Q3 2019 Results - Earnings Call Transcript
Alexion Pharmaceuticals Inc (ALXN)
Q3 2019 Results Earnings Conference Call
October 23, 2019 08:00 A.M. ET
Company Participants
Susan Altschuller - Vice President, Investor Relations
Ludwig Hantson - CEO
Paul Clancy - Chief Financial Officer
John Orloff - Global Head of R&D
Brian Goff - Chief Commercial Officer
Aradhana Sarin - Chief Strategy and Business Officer and Incoming CFO
Conference Call Participants
Josh Schimmer - Evercore ISI
Matthew Harrison - Morgan Stanley
Geoffrey Porges - SVB Leerink
Chris Raymond - Piper Jaffray
Phil Nadeau - Cowen & Company
Geoff Meacham - Bank of America
Paul